The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Berard, L., Cameron, B. R., Woo, V. C., & Stewart, J. A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.12.008 · Cited by 8
Petrovski, G., Gjergji, D., Grbić, A., Vuković, B., Krajnc, M., & Grulović, N. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0467-4 · Cited by 8
Hypoglycaemia in Type 2 Diabetes and in Elderly People
Zammitt, N. N., & Frier, B. M. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch12 · Cited by 8
Wong, C. K. H., Tong, T., Cheng, G. H. L., Tang, E. H. M., Thokala, P., Tse, E. T. Y., & Lam, C. L. K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13657 · Cited by 7
Pienimäki, T. (2014) · Cited by 7
Carew, A. S., Warren, R. A., Bancks, M. P., Espeland, M. A., Bahnson, J. L., Lewis, C. E., Levy, A. P., Sapp, J. L., Urquhart, R., Wang, J. L., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02448-z · Cited by 7
Evidence-Based Practice Use of Incretin-Based Therapy in the Natural History of Diabetes
Schwartz, S. S. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2757 · Cited by 8
Lum, E., Jiménez, G., Huang, Z., Thai, L., & Car, J. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3235 · Cited by 7
Alghamdi, E. M., Alghubayshi, L. A., Alshamrani, R., Alnajashi, R. A., Alamoudi, E. A., Aljabarti, A. M., & ZARIF, H. A. (2020) · Cureus · doi:10.7759/cureus.6742 · Cited by 7
Hung, W.-T., Chen, Y.-J., Cheng, C.-Y., Ovbiagele, B. I., Lee, M., & Hsu, C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109937 · Cited by 7
Shao, Y., Shao, F., Zhou, J., Fang, S., Zhu, J., & Li, F. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/166656 · Cited by 7
Tabesh, M., Sacre, J. W., Mehta, K., Chen, L., Sajjadi, S. F., Magliano, D. J., & Shaw, J. E. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15938 · Cited by 7
Ross, S. A., Dzida, G. J., Ji, Q., Kaiser, M., Ligthelm, R. J., Meneghini, L., Nazeri, A., Orozco‐Beltrán, D., Pan, C., Svendsen, A. L., et al. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12091 · Cited by 7
Ryan, G. J. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1095616 · Cited by 7
Current Issues in Glp-1 Receptor Agonist Therapy for Type 2 Diabetes
Bloomgarden, Z. T., Blonde, L., Garber, A. J., & Wysham, C. (2012) · Endocrine Practice · doi:10.4158/ep12300.ra · Cited by 7
Reevaluating Goals of Insulin Therapy: Perspectives from Large Clinical Trials
Riddle, M. C., & Yuen, K. C. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.003 · Cited by 7
Li, J., Feng, Z., Li, Q., He, Y. L., ZHAO, C., & He, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1688 · Cited by 7
Self-citationPenna, G., Gontijo, E. D., Mendes, H. G., dos Santos, A. D. F., Rodrigues, A. C., do Nascimento, M. F. J., de Herculano, B. S., Eliazar, G. C., & Bergmann, K. (2016) · Revista Médica de Minas Gerais · doi:10.5935/2238-3182.20160075 · Cited by 8
Minamoto-Higashioka, M., Kawamura, R., Umakoshi, H., Yokomoto‐Umakoshi, M., Utsunomiya, D., Osawa, H., & Kondo, S. (2019) · Internal Medicine · doi:10.2169/internalmedicine.1360-18 · Cited by 7
Home, P., & Itzhak, B. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001077 · Cited by 7
Jensen, M. H., Hejlesen, O. K., & Vestergaard, P. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14263 · Cited by 7
Recomendaciones para el manejo del riesgo cardiorrenal en el paciente con diabetes mellitus tipo 2
Castillo, G. A., Aroca, G., Buelvas, J., Buitrago, A. F., Carballo-Zárate, V., Cárdenas, J. M., Gómez, E. A., Fériz, K., Lopera, J. M., Enrique Melgarejo, R., et al. (2020) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2020.07.005 · Cited by 7
Desouza, C. V., Kirk, A. R., Mangla, K. K., Wolden, M. L., & Lingvay, I. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001830 · Cited by 8
Federici, M. O., Gentilella, R., Corcos, A., Torre, E., & Genovese, S. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3434 · Cited by 7
Takayama, K., Fujii, K., Yamaguchi, H., Miyoshi, Y., Uehara, Y., Nagata, S., Obata, Y., Kosugi, M., Hazama, Y., & Yasuda, T. (2021) · Internal Medicine · doi:10.2169/internalmedicine.5578-20 · Cited by 7
Moulton, M. K., Johnson, B. R., Lavender, D. L., Osae, S. P., Phillips, B. B., Thomas, I., & Stone, R. H. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280211071089 · Cited by 7
Influence of acute glycaemic level on measures of myocardial infarction in non-diabetic pigs.
Diemar, S. S., Sejling, A., Iversen, K. K., Engstrøm, T., Hønge, J. L., Tønder, N., Vejlstrup, N. G., Idorn, M., Ekström, K., Pedersen‐Bjergaard, U., et al. (2015) · PubMed · doi:10.3109/14017431.2015.1085079 · Cited by 7
Yang, X., Lu, J., Weng, J., Gu, W., Guo, X., Zou, D., Zhou, Z., Zhu, D., Ji, Q., Ji, L., et al. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s66915 · Cited by 7
Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz
Clodi, M., Säly, C., Hoppichler, F., Resl, M., Steinwender, C., & Eber, B. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-0988-7 · Cited by 7
Patient Understanding of Hypoglycemia in Tertiary Referral Centers
Cho, N. H., Kim, N. K., Han, E., Hong, J. H., Jeon, E. J., Moon, J. S., Seo, M. H., Lee, J. E., Seo, H.-A., Kim, M. K., et al. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.43 · Cited by 7
Hypoglycaemia in hospitalized patients with or without heart failure
Merrill, J. D., & Dungan, K. M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13376 · Cited by 7
McCoy, R. G., Lipska, K. J., Houten, H. K. V., & Shah, N. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001878 · Cited by 7
Settles, J. A., Kan, H. J., Child, C. J., Gorritz, M., Multani, J. K., McGuiness, C. B., Wade, R. L., & Frier, B. M. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14690 · Cited by 7
Lee, Y., Bae, Y., Kim, H., Park, J., Kwon, S. Y., Park, S., Kim, G., Hur, K. Y., Kim, J. H., & Jin, S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110083 · Cited by 7
Hayes, K. N., Berry, S. D., Munshi, M. N., & Zullo, A. R. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18360 · Cited by 7
Gupta, T., & Hudson, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1055 · Cited by 7
Almomani, H. Y., Pascual, C., Al-Azzam, S. I., & Ahmadi, K. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.07.012 · Cited by 7
Dangers of Hypoglycemia in Cardiac Patients With Diabetes
DEEDWANIA, P. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2138 · Cited by 7
Almomani, H. Y., Pascual, C., Grassby, P. F., & Ahmadi, K. (2022) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2022.09.017 · Cited by 7
Dhaliwal, K. K., Watson, K. E., Lamont, N. C., Drall, K. M., Donald, M., James, M. T., Robertshaw, S., Verdin, N., Benterud, E., McBrien, K., et al. (2023) · Health Expectations · doi:10.1111/hex.13789 · Cited by 6
Karter, A. J., Parker, M. M., Huang, E. S., Seligman, H. K., Moffet, H. H., Ralston, J. D., Liu, J. Y., Gilliam, L. K., Laiteerapong, N., Grant, R. W., et al. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08801-y · Cited by 6
Andriessen, C., Blom, M. T., van Hoek, B. A. C. E., de Boer, A. W., Denig, P., de Wit, G. A., Swart, K. M. A., de Rooij-Peek, A., van Marum, R. J., Hugtenburg, J. G., et al. (2024) · Trials · doi:10.1186/s13063-024-08249-9 · Cited by 6
Ohno, T., Tsujino, D., & Nishimura, R. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2400487 · Cited by 6
Diabetes treatment: The coming paradigm shift
Bloomgarden, Z. T. (2012) · Journal of Diabetes · doi:10.1111/1753-0407.12005 · Cited by 6
Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 Diabetes
Hinnen, D. A. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715609420 · Cited by 6
CVOTs: What did the endocrinologist learn?
Valensi, P. E., & Prévost, G. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107947 · Cited by 6
Orsi, E., Bonora, E., Solini, A., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Zerbini, G., Morano, S., Nicolucci, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010246 · Cited by 6
Yamaji, T., Harada, T., Hashimoto, Y., Takaeko, Y., Kajikawa, M., Han, Y., Maruhashi, T., Kishimoto, S., Hashimoto, H., Kihara, Y., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045415 · Cited by 6
Bahrmann, A., Wernecke, J., Bahrmann, P., Kopf, D., & Zeyfang, A. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0978-y · Cited by 6
Nutrition-related Risk and Severe Hypoglycemia in Older Adult Outpatients with and without Diabetes
Kimura, Y., Kimura, N., & Akazawa, M. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5317 · Cited by 6
The severity and duration of Hypoglycemia affect platelet-derived protein responses in Caucasians
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01639-w · Cited by 6
Pīrāgs, V., El‐Damasy, H., Dąbrowski, M., Gönen, M. S., Račická, E., Martinka, E., Giaconia, J. M., Stefański, A., & On Behalf of the B001 Study Investigators (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03001.x · Cited by 6
Nobels, F. R. E., D’Hooge, D., & Crenier, L. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.695730 · Cited by 6
Severe Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes
Park, H. K. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.478 · Cited by 6
Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus
Tada, Y., Kanazawa, I., Notsu, M., Tanaka, K.-I., Kiyohara, N., Sasaki, M., & Sugimoto, T. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6011 · Cited by 6
The dynamics of invasive and noninvasive blood glucose monitoring methods: Recent trends
Babenko, A. Y., Kononova, Y. A., Tsiberkin, A. I., Khodzitsky, M. K., & Grineva, E. N. (2016) · Diabetes Mellitus · doi:10.14341/dm7760 · Cited by 6
Raghavan, S., Liu, W. G., Ho, P. M., Plomondon, M. E., Barón, A. E., Caplan, L., Maddox, K. E. J., Magid, D. J., Saxon, D. R., Voils, C. I., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.010 · Cited by 6
Association of Tramadol and Hypoglycemia in Diabetic Asians
Li, S.-Y., Chen, H., Lin, C., Yeh, S.-Y., & Kao, C. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110380 · Cited by 6
Xu, L., Zhang, P., Huang, Z., Zhong, L., Li, H., Liu, L., Liu, J., Xiao, H., & Li, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4097469 · Cited by 6
Gotfredsen, D. R., VINTHER, S. M., Petersen, T. S., Cortes, R., Jensen, T. B., Jimenez‐Solem, E., & Christensen, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60818-5 · Cited by 6
Ishikawa-Tanaka, T., Hosojima, M., Kabasawa, H., Kaseda, R., Yasukawa, R., Yata, Y., Kuwahara, S., Kono, E., Takata, T., Iino, N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00928-5 · Cited by 6
Acute coronary syndrome in diabetes mellitus: features of pathogenesis, course and therapy
Kokozheva, M. A., Марданов, Б. У., & Мамедов, М. Н. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20212402189 · Cited by 6
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus
Evans, M., Morgan, A. R., & Bain, S. C. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01061-7 · Cited by 6
Accelerated decline of renal function in type 2 diabetes following severe hypoglycemia
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.015 · Cited by 6
Shigiyama, F., Kumashiro, N., Fuchigami, A., & Hirose, T. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0730-z · Cited by 6
Urbanová, J., Brunerová, L., & Brož, J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107914 · Cited by 6
Busch, M., Lehmann, T., Wolf, G., Günster, C., Müller, U., & Muller, N. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1129-6699 · Cited by 6
Alessi, J., Teló, G. H., de Oliveira, G. B., Schneiders, J., Zanella, M. J. B., & Schaan, B. D. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107835 · Cited by 6
Jialal, I., & Dhindsa, S. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.006 · Cited by 6
Gani, L. U., Lau, E. S. H., Luk, A. O. Y., Sobrepeña, L., Tran, Q. K., Kesavadev, J., Jia, W., Yu, W., Tsang, C. C., Mukhopadhyay, M., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12843 · Cited by 6
Cardiovascular Disease (CVD) Limbo: How Soon and Low Should We Go to Prevent CVD in Diabetes?
Maahs, D. M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0078 · Cited by 6
Chen, J., Chan, M., Fan, P., Tsai, T.-Y., Yen, C., Hsiao, C.-C., Lee, C., Lin, C., Chen, Y., Yang, C.-W., et al. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.12.007 · Cited by 5
Guo, F.-S., Dou, J., Wang, J.-X., Guo, C. Y., Wu, R., Sun, X.-L., Hu, Y.-W., & Wei, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01671-2 · Cited by 6
Managing Diabetes in Older Adults: Current Approaches in Long-Term Care Facilities
Idrees, T., Castro-Revoredo, I., KANTIPUDI, S. L., & Umpierrez, G. E. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01583-5 · Cited by 5
Pathak, G., Mangla, S., Bhan, V., Ahlawat, Y. K., Sharma, N., Malik, A., Gautam, P., Verma, R., Gupta, S., & Bisht, K. (2026) · Phytotherapy Research · doi:10.1002/ptr.70213 · Cited by 5
Dey, A. K., Groenendyk, J., Mehta, N. N., & Gourgari, E. (2019) · Clinical Cardiology · doi:10.1002/clc.23152 · Cited by 5
Detecting Physiological Changes in Humans: Medical Alert and Assistance Dogs
Reeve, C., & Wilson, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-39370-9_13 · Cited by 5
Practical Considerations in the Management of Frail Older People with Diabetes
Abdelhafiz, D., & Abdelhafiz, A. H. (2025) · Diseases · doi:10.3390/diseases13080249 · Cited by 7
Braatvedt, G. D., Sykes, A. J., Panossian, Z., & McNeill, D. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0024 · Cited by 5
Función plaquetaria e hiperglucemia en el síndrome coronario
Puig‐Domingo, M. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.08.012 · Cited by 6
Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial
Azar, M., Lyons, T. J., Alaupovic, P., Stoner, J. A., Quiroga, C., Kaufman, D., Lopes-Virella, M. F., Klein, R. L., & Jenkins, A. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.05.005 · Cited by 5
Impact on mortality of systolic and/or diastolic heart failure in the elderly—10 years of follow-up
Olofsson, M., & Boman, K. (2015) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2014.10.002 · Cited by 5
Gusev, S. I., Сергеевич, Б. Н., Sedykh, E. A., Kononova, Y. A., Litvinenko, E. V., Goryachuk, A. A., Begaeva, V. A., Babenko, A. Y., Grineva, E. N., & Khodzitsky, M. K. (2016) · Journal of Physics Conference Series · doi:10.1088/1742-6596/735/1/012088 · Cited by 5
Takeishi, S., Mori, A., Kawai, M., Yoshida, Y., Hachiya, H., Yumura, T., Ito, S., Shibuya, T., Fushimi, N., Ohashi, N., et al. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.7085 · Cited by 5
Kala, P., Jamuna Rani, R., & Kumar, J. S. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i12.22050 · Cited by 5
Mohan, V., WANGNOO, S. K., Das, S., Dhediya, R., & Gaurav, K. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i12.1168 · Cited by 5
Aldafas, R., Crabtree, T. S. J., Vinogradova, Y., Gordon, J. P., & IDRIS, I. R. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2166489 · Cited by 5
Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)
Clodi, M., Saely, C. H., Hoppichler, F., Resl, M., Steinwender, C., Stingl, H., Wascher, T. C., Winhofer, Y., & Sourij, H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02183-7 · Cited by 5
Ruiz, M. D., Márquez, M. A. C., & Armas, R. M. (2013) · Revista de la Facultad de Medicina (México) · Cited by 5
Optimal Glycemic Control in the Elderly: Where is the Evidence and Who Should Be Targeted?
Tessier, D. (2011) · Aging Health · doi:10.2217/ahe.10.86 · Cited by 5
Effects of insulin detemir on balloon catheter injured carotid artery in Zucker fatty rats
Murthy, S. N., Pankey, E. A., Banka, A. A., Badejo, A. M., Wekerle, R., Vilija, V., Izadpanah, R., Kadowitz, P. J., & Fonseca, V. A. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.05.019 · Cited by 5
Platelet Function and Hyperglycemia in Acute Coronary Syndrome
Puig‐Domingo, M. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.08.011 · Cited by 5
Hypoglycemia in critically ill adults - association yes, causation not proven
Finfer, S. R. (2011) · Critical Care · doi:10.1186/cc10427 · Cited by 5
Morimoto, A., Nishimura, R., Tsujino, D., Taki, K., Tajima, N., & Utsunomiya, K. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0230 · Cited by 5
Glycemic Variability: Clinical and Prognostic Significance
Lin, K. Y. H., Huang, K.-J., & Yang, C. (2015) · Diabetes Research - Open Journal · doi:10.17140/droj-1-108 · Cited by 5
D’Netto, M. E., Murphy, C. V., Mitchell, A., & Dungan, K. M. (2015) · Hospital Practice · doi:10.1080/21548331.2016.1130584 · Cited by 5
Takeishi, S., Mori, A., Kawai, M., Yoshida, Y., Hachiya, H., Yumura, T., Ito, S., Shibuya, T., Fushimi, N., Ohashi, N., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7971 · Cited by 5
Wang, G., Bi, Y., Liu, X., Meng, W., & Zhang, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7967 · Cited by 5
Khalil, S. S., Ali, H. A., Al-Saadawy, H. A., & El-Dawy, K. (2018) · Slovenian Veterinary Research · doi:10.26873/svr-654-2018 · Cited by 5
Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2019)
Clodi, M., Saely, C. H., Hoppichler, F., Resl, M., Steinwender, C., Stingl, H., Wascher, T. C., Winhofer-Stöckl, Y., & Sourij, H. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1488-3 · Cited by 5
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
